Literature DB >> 1385539

Homogeneity of lipopolysaccharide antigens in Pseudomonas pseudomallei.

T L Pitt1, H Aucken, D A Dance.   

Abstract

An antiserum raised against a single strain of Pseudomonas pseudomallei reacted equally in a whole cell agglutination test, an indirect haemagglutination (IHA) test and an ELISA with a panel of 12 strains of the species which had been isolated from human beings and animals in various parts of the Far East and Australia between 1923 and 1990. Absorption of the serum with either of two strains removed all reactivity of the serum with other strains. Phenol-water extracted lipopolysaccharide (LPS) from a single strain blocked the reactivity of the serum with red cells sensitised with crude extracts of any of the panel of strains, thereby suggesting that the 'common' antigen was LPS. This antigen was not detected in other Pseudomonas species with the exception of Pseudomonas mallei. Protease K-digested extracts of the 12 strains gave highly similar silver-stained LPS banding patterns in gel electrophoresis. Furthermore, immunoblots of LPS with either rabbit or a patient's serum showed identical ladder profiles for each strain. The results suggest that the LPS antigen is highly conserved throughout P. pseudomallei and that this antigen is detected by the IHA test.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385539     DOI: 10.1016/0163-4453(92)93920-l

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  11 in total

1.  Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei.

Authors:  L E Bryan; S Wong; D E Woods; D A Dance; W Chaowagul
Journal:  Can J Infect Dis       Date:  1994-07

2.  Revised structures for the predominant O-polysaccharides expressed by Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Christian Heiss; Mary N Burtnick; Rosemary A Roberts; Ian Black; Parastoo Azadi; Paul J Brett
Journal:  Carbohydr Res       Date:  2013-08-24       Impact factor: 2.104

3.  Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies.

Authors:  M Ho; T Schollaardt; M D Smith; M B Perry; P J Brett; W Chaowagul; L E Bryan
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

4.  Lipopolysaccharide profile typing as a technique for comparative typing of gram-negative bacteria.

Authors:  H M Aucken; T L Pitt
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

5.  Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei.

Authors:  M B Perry; L L MacLean; T Schollaardt; L E Bryan; M Ho
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Latex agglutination test for identification of Pseudomonas pseudomallei.

Authors:  M D Smith; V Wuthiekanun; A L Walsh; T L Pitt
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

7.  Use of a Western blot technique for the serodiagnosis of glanders.

Authors:  Mandy C Elschner; Holger C Scholz; Falk Melzer; Muhammad Saqib; Peggy Marten; Astrid Rassbach; Michael Dietzsch; Gernot Schmoock; Vania L de Assis Santana; Marcilia M A de Souza; Renate Wernery; Ulrich Wernery; Heinrich Neubauer
Journal:  BMC Vet Res       Date:  2011-01-19       Impact factor: 2.741

8.  Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes.

Authors:  Paul J Brett; Mary N Burtnick; D Scott Snyder; Jeffrey G Shannon; Parastoo Azadi; Frank C Gherardini
Journal:  Mol Microbiol       Date:  2006-12-05       Impact factor: 3.501

9.  Misdiagnosing melioidosis.

Authors:  Andrew J Brent; Philippa C Matthews; David A Dance; Tyrone L Pitt; Rupert Handy
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

10.  Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates.

Authors:  N Anuntagool; P Intachote; V Wuthiekanun; N J White; S Sirisinha
Journal:  Clin Diagn Lab Immunol       Date:  1998-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.